9 ASX 200 shares attracting 'strong buy' ratings from the experts

There is a consensus 'strong buy rating' on these stocks from analysts on the CommSec trading platform.

A team of people giving the thumbs up sign.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) shares rose 2.35% in July and finished the month at 8,742.8 points on Thursday.

The benchmark index closed 0.92% lower yesterday at 8,662 points.

In July, the experts upgraded these nine ASX 200 shares to strong buy ratings.

Let's check them out.

9 ASX 200 shares with strong buy ratings

The following ASX 200 shares received an upgraded 'strong buy' consensus rating on the CommSec platform in July.

Telix Pharmaceuticals Ltd (ASX: TLX)

The consensus rating on Telix Pharmaceuticals shares was upgraded to a strong buy on 31 July.

The Telix share price finished the session on Friday at $20.15, down 4.28%.

Bell Potter has a buy rating on this ASX 200 tech share with a 12-month price target of $34.

Worley Ltd (ASX: WOR)

Commsec analysts reached a consensus 'strong buy' rating on Worley shares on 31 July.

The Worley share price closed at $13.38, up 0.22% yesterday.

CSL Ltd (ASX: CSL)

The consensus rating on CSL shares was upgraded to a strong buy on 22 July.

The CSL share price finished last week at $264.05, down 2.53%.

Bell Potter has a buy rating on the ASX 200 healthcare share with a 12-month price target of $305. 

Orica Ltd (ASX: ORI)

Commsec analysts reached a consensus 'strong buy' rating on Orica shares on 22 July.

The Orica share price finished the session on Friday at $21.30, down 0.37%.

UBS has a buy rating on the explosives manufacturer with a 12-month share price target of $32. 

WiseTech Global Ltd (ASX: WTC)

The consensus rating on WiseTech Global shares was upgraded to a strong buy on 22 July.

The WiseTech Global share price finished the session on Friday at $116.34, down 3.04%.

Bell Potter has a buy rating on the ASX 200 tech share and a 12-month target price of $135.

Air New Zealand Ltd (ASX: AIZ)

Commsec analysts reached a consensus 'strong buy' rating on Air New Zealand shares on 31 July.

The ASX 200 airline share closed at $116.34 on Friday, down 2.55%.

But wait, there's more!

Capstone Copper Corp (ASX: CSC)

The consensus rating on Capstone Copper shares was upgraded to a strong buy on 22 July.

Capstone Copper shares led the market on Friday after the miner reported record production.

The ASX 200 copper stock was the fastest riser of the day, up 9.46% to $9.37.

Macquarie has an outperform rating on the ASX 200 copper share with a price target of $13.30. 

Zip Co Ltd (ASX: ZIP)

Commsec analysts reached a consensus 'strong buy' rating on this ASX 200 buy now, pay later stock on 22 July.

The Zip share price finished the week at $3.25, up 0.62%.

Blackwattle portfolio managers Robert Hawkesford and Daniel Broeren said Zip shares still have 'meaningful upside'.

They commented:

We still see meaningful upside through the ongoing penetration of BNPL products in the US which has a significant runway, sitting at only ~2% today, vs ~15% and ~20% in Australia and Europe respectively.

Westgold Resources Ltd (ASX: WGX)

The consensus rating on Westgold Resources shares was upgraded to a strong buy on 22 July.

The Westgold Resources share price closed at $2.53, down 1.17%, yesterday.

Macquarie has an outperform rating on the ASX 200 gold share with a 12-month share price target of $3.60. 

Motley Fool contributor Bronwyn Allen has positions in CSL and Zip Co. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Macquarie Group, Telix Pharmaceuticals, WiseTech Global, and Zip Co. The Motley Fool Australia has positions in and has recommended Macquarie Group and WiseTech Global. The Motley Fool Australia has recommended CSL and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Endeavour, ResMed, and Westpac shares

Let's see what analysts are saying about these big names.

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A team of people giving the thumbs up sign.
Broker Notes

7 ASX 200 shares upgraded to strong buy ratings

Looking for investment inspiration?

Read more »

Two young male miners wearing red hardhats stand inside a mine and shake hands
Broker Notes

Macquarie tips 23% upside for resurgent ASX 200 copper stock riding the red metal's bull run

Macquarie expects more outperformance from this surging ASX 200 copper stock.

Read more »

A woman pulls her jumper up over her face, hiding.
Energy Shares

Is there a downside ahead for Origin Energy shares?

Here's what the broker expects over the next 12 months.

Read more »

A woman in a red dress holding up a red graph.
Industrials Shares

Macquarie tips more than 60% upside for this ASX All Ords stock

This professional services firm's shares are looking cheap, Macquarie says.

Read more »

Happy young woman saving money in a piggy bank.
Broker Notes

Are Westpac shares a buy following the bank's $7 billion FY25 profit result? Here's Macquarie's recommendation

Macquarie just updated its price target for Westpac shares. Here’s why.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Macquarie is tipping a 30% return for Resmed shares

This blue chip gets a big thumbs up from analysts at Macquarie.

Read more »